scieee Science in your language
[en] (orig)

Efficient delivery of small interfering RNA for inhibition of IL-12p40 expression in vivo

Abstract

Background: RNA interference is an evolutionary conserved immune response mechanism that can be used as a tool to provide novel insights into gene function and structure. The ability to efficiently deliver small interfering RNA to modulate gene expression in vivo may provide new therapeutic approaches to currently intractable diseases. Methods: In vitro, siRNA targeting IL-12p40 was delivered to the murine macrophage cell line (J774A.1) encapsulated in a liposome with an IL-12 inducing agent (LPS/IFN-γ) over a number of time points. Controls included a variety of non-target specific siRNA reagents. Supernatants were analyzed for cytokine production while the cells were removed for mRNA profiling. In vivo, siRNA-targeting IL-12p40 was delivered to the murine peritoneal cavity in a therapeutic fashion, after endotoxin (LPS) challenge. Cells from the peritoneal cavity were removed by lavage and analyzed by flow cytometry. Levels of IL-12 present in lavage and in serum were also examined by ELISA. Results: In this report, we show that IL-12p40 siRNA can specifically silence macrophage expression of IL-12p40 mRNA and IL-12p70 protein in vitro. We extend this finding to demonstrate that delivery of liposome encapsulated siRNA targeting IL-12p40 to the murine peritoneal cavity can modulate an inflammatory stimulus in vivo. Furthermore, specific siRNA can be used therapeutically after endotoxin challenge to reduce both the local and systemic inflammatory response. Thus, the delivery of siRNA can be used to elicit specific non-permanent inhibition of endogenous protein expression. Conclusion: In vitro silencing of IL-12p40 using siRNA at selected doses leads to specific knockdown of IL-12p70 protein production without inducing type I interferons. Furthermore, siRNA targeting murine IL-12p40 can be used therapeutically to counter an inflammatory response in vivo.

Read accessible full text

Efficient delivery of small interfering RNA for inhibition of IL-12p40 expression in vivo

Author: Mahon, Bernard P.,Flynn, Marion A.,Casey, David G.,Todryk, Stephen M.
Publisher: BioMed Central
Year: 2004
Source: https://mural.maynoothuniversity.ie/id/eprint/157/1/MahonJInflam.pdf
BioMed Cen al
Page 1 o 12
(page numbe no o ci a ion pu poses)
Jou nal o In lamma ion
Open Access
Resea ch
E icien deli e y o small in e e ing RNA o inhibi ion o IL-12p40
exp ession in i o
Ma ion A Flynn†, Da id G Casey†, S ephen M Tod yk and Be na d P Mahon*
Add ess: Ins i u e o Immunology, Na ional Uni e si y o I eland, Maynoo h, Co. Kilda e, I eland
Email: Ma ion A Flynn - ma ion.a. [email protected]; Da id G Casey - [email p o ec ed]; S ephen M Tod yk - s ephen. od yk@clinical-
medicine.ox o d.ac.uk; Be na d P Mahon* - bpmaho[email p o ec ed]
* Co esponding au ho †Equal con ibu o s
Abs ac
Backg ound: RNA in e e ence is an e olu iona y conse ed immune esponse mechanism ha
can be used as a ool o p o ide no el insigh s in o gene unc ion and s uc u e. The abili y o
e icien ly deli e small in e e ing RNA o modula e gene exp ession in i o may p o ide new
he apeu ic app oaches o cu en ly in ac able diseases.
Me hods: In i o, siRNA a ge ing IL-12p40 was deli e ed o he mu ine mac ophage cell line
(J774A.1) encapsula ed in a liposome wi h an IL-12 inducing agen (LPS/IFN-γ) o e a numbe o
ime poin s. Con ols included a a ie y o non- a ge speci ic siRNA eagen s. Supe na an s we e
analyzed o cy okine p oduc ion while he cells we e emo ed o mRNA p o iling.
In i o, siRNA- a ge ing IL-12p40 was deli e ed o he mu ine pe i oneal ca i y in a he apeu ic
ashion, a e endo oxin (LPS) challenge. Cells om he pe i oneal ca i y we e emo ed by la age
and analyzed by low cy ome y. Le els o IL-12 p esen in la age and in se um we e also examined
by ELISA.
Resul s: In his epo , we show ha IL-12p40 siRNA can speci ically silence mac ophage
exp ession o IL-12p40 mRNA and IL-12p70 p o ein in i o. We ex end his inding o demons a e
ha deli e y o liposome encapsula ed siRNA a ge ing IL-12p40 o he mu ine pe i oneal ca i y
can modula e an in lamma o y s imulus in i o. Fu he mo e, speci ic siRNA can be used
he apeu ically a e endo oxin challenge o educe bo h he local and sys emic in lamma o y
esponse. Thus, he deli e y o siRNA can be used o elici speci ic non-pe manen inhibi ion o
endogenous p o ein exp ession.
Conclusion: In i o silencing o IL-12p40 using siRNA a selec ed doses leads o speci ic
knockdown o IL-12p70 p o ein p oduc ion wi hou inducing ype I in e e ons. Fu he mo e,
siRNA a ge ing mu ine IL-12p40 can be used he apeu ically o coun e an in lamma o y esponse
in i o.
Backg ound
RNA in e e ence (RNAi) is an e olu iona y conse ed
sequence-speci ic RNA silencing mechanism ound as an
an i- i al esponse in in e eb a es, plan s and mamma-
lian cells [1]. Al hough he mechanism o silencing is no
comple ely unde s ood, he basic p emise o RNAi es s
Published: 01 Oc obe 2004
Jou nal o In lamma ion 2004, 1:4 doi:10.1186/1476-9255-1-4
Recei ed: 28 June 2004
Accep ed: 01 Oc obe 2004
This a icle is a ailable om: h p://www.jou nal-in lamma ion.com/con en /1/1/4
© 2004 Flynn e al; licensee BioMed Cen al L d.
This is an open-access a icle dis ibu ed unde he e ms o he C ea i e Commons A ibu ion License (h p://c ea i ecommons.o g/licenses/by/2.0),
which pe mi s un es ic ed use, dis ibu ion, and ep oduc ion in any medium, p o ided he o iginal wo k is p ope ly ci ed.
Jou nal o In lamma ion 2004, 1:4 h p://www.jou nal-in lamma ion.com/con en /1/1/4
Page 2 o 12
(page numbe no o ci a ion pu poses)
on he abili y o double s anded RNA (dsRNA) o speci -
ically deg ade homologous messenge RNA (mRNA). The
RNAi pa hway is igge ed in mammalian cells by he
p esence o dsRNA o in he p esence o sho 19–22n
dsRNA agmen s e med small in e e ing RNA molecules
(siRNA). siRNA molecules ac i a e an RNA-induced
silencing complex (RISC) ha unwinds he siRNA duplex
[2]. The speci ici y o locus deg ada ion is guided by he
an isense s and o he unwound siRNA, ollowed by
sense s and siRNA binding o he complemen a y mRNA
si e o clea age by RISC. The clea age o he sense s and
siRNA and a ge mRNA esul s in he sel -ampli ying p o-
duc ion o new siRNA in e media ies ha con inue
mRNA a ge deg ada ion in an ATP dependen manne
[3,4]. This phenomenon means ha low doses o siRNA
can be mo e e ec i e han an isense he apy. Fu he -
mo e, his app oach is p e e able o gene and an isense
based he apies, in ha siRNA is non-he i able and does
no equi e adeno i al ec o s, which limi he e ec i e-
ness and accep abili y o use in child en.
RNAi can be exploi ed as a ool o p o ide no el insigh s
in o gene unc ion and s uc u e. The capaci y o e i-
cien ly deli e siRNA o modula e gene exp ession in i o
may p o ide new he apeu ic app oaches o cu en ly
in ac able diseases. Like o he new gene ic echnologies,
siRNA gene supp ession aces se e al me hodological lim-
i a ions in i o. Fo emos among hese a e he e icien
deli e y o siRNA o a ge cells [5,6], non-speci ic e ec s
o pu a i e con ol duplexes [7-9] and he po en ial he a-
peu ic p oblems o i al exp ession ec o s [10]. One
app oach o o e coming hese obs acles is o deli e non-
he i able siRNA duplexes in a model sys em and moni o
he in luence upon expe imen ally induced in lamma-
ion. This app oach would p o ide a me hod ha allows
he apid sc eening o wha ha e been e med "d uggable"
a ge s [11].
In e leukin-12 (IL-12p70) is a cy okine wi h a well-cha -
ac e ized p o-in lamma o y unc ion [12] ha has been
sugges ed as a a ge o he apeu ic in e en ion [13-15].
Bioac i e IL-12p70 is a he e odime o med by a hea y
chain (p40) and a ligh chain subuni (p35), encoded by
wo sepa a e genes whose exp ession is independen ly
egula ed a he ansc ip ional le el [16]. The p35 sub-
uni is cons i u i ely exp essed a low le els in mos cell
ypes bu is up egula ed du ing cell ac i a ion. In con-
as , he IL-12p40 gene is unde igh ansc ip ional con-
ol only exp essed in mac ophages o o he APC
ollowing ac i a ion by mic obial p oduc s [17]. P oduc-
ion o IL-12p70 is enhanced by IFN-γ ia he IFN consen-
sus sequence binding p o ein [18] bu educed by IL-10
[19].
IL-12p70 has pleio opic e ec s on a ge cells bu he
majo ole is as a p o-in lamma o y cy okine in cell medi-
a ed immuni y agains mic obial insul . In pa icula IL-
12p70 ac s upon T and NK cells o inc eases cy okine p o-
duc ion, p oli e a ion, and cy o oxici y, unc ions ha
become e iden se e al hou s a e exposu e o in ec ions
agen s [19]. The IFN-γ subsequen ly p oduced, po en ia es
an igen p esen a ion unc ions impo an in clea ing
in ec ious agen s. These unc ions include inc eased co-
s imula o y molecule exp ession, phagocy osis, and p o-
duc ion o eac i e oxygen and ni ogen in e media es
[19,20]. Howe e , IL-12p70 is no always p o ec i e o
bene icial, indeed a a ie y o pa hological condi ions,
including sepsis, a e associa ed wi h IL-12 d i en pa hol-
ogy [21,22]. In addi ion o he well-cha ac e ized ole o
IL-12p70, i is now known ha he IL-12p40 subuni is
also biologically ac i e. This subuni may ac o an ago-
nize he he e odime unc ion [23], o may ha e a b oade
di ec ole, less dependen on IL-12p70 [24,25].
In o de o explo e he he apeu ic easibili y o RNA in e -
e ence, we used siRNA o speci ically abla e IL-12p40
exp ession in i o and in i o. This app oach ex ends he
powe o RNA in e e ence o gene exp ession s udies in
li e animals wi hou he use o gene ic enginee ing, plas-
mid DNA epo e sys ems [2,26] e o i al [27,28] o len-
i i al siRNA exp ession ec o s [29] and opens he way
o explo ing he use o siRNA in humans o ea disease.
Ou esul s p o ide a desc ip ion o siRNA media ed sup-
p ession o an endogenous immune gene in i o and
desc ibe a no el he apeu ic and esea ch app oach o
gene speci ic inhibi ion o an impo an cellula and
immunological esponse.
Ma e ials and Me hods
Mice & Cell Lines
Female BALB/c mice (Ha lan Limi ed, Bices e , UK) and
IL-12p40 gene-dis up ed mice (IL12p40-/-) (Jackson Lab-
o a o ies, Ba Ha bo , Maine) we e main ained unde he
guidelines o he I ish Depa men o Heal h and he local
bioe hics commi ee. All mice we e 12–14 weeks old a
he ini ia ion o expe imen s and sac i iced on comple-
ion. The mu ine mac ophage cell line (J774A.1) was used
o in es iga e silencing o IL-12p40 cy okine gene
exp ession.
P epa a ion o siRNA
siRNA oligonucleo ides wi h he ollowing sense and an i-
sense sequences we e designed om he GenBank eposi-
o y: accession numbe ; NM_008352, Mus musculus
in e leukin 12b (IL12b), mRNA. IL-12p40 siRNA 5'-C
CUC ACC UGU GAC ACG CCU dTdT-3' (sense) and 3'-
dTdT G GAG UGG ACA CUG UGC GGA-5' (an isense);
Mu an siRNA 5'-C CUC ACC UUC GAC ACG CCU dTdT-
3' (sense) and 3'-dTdTG GAG UGG AAG CUG UGC GGA-
Jou nal o In lamma ion 2004, 1:4 h p://www.jou nal-in lamma ion.com/con en /1/1/4
Page 3 o 12
(page numbe no o ci a ion pu poses)
5' (an isense); GFPsiRNA 5'-GGC UAC GUC CAG GAG
CGC ACC dTdT-3' (sense) and 3'-dTdT CCG AUG CAG
GUC CUC GCG UGG-5' (an isense). The an isense o he
IL-12p40 siRNA duplex (As.RNA) was also used as a con-
ol o in i o expe imen s. Each complemen a y RNA
s and was dep o ec ed acco ding o manu ac u e 's
ins uc ions. Fo he p oduc ion o he IL-12p40 siRNA
duplex, sense and an isense siRNA s ands we e mixed in
equimola a ios and ea ed by hea ing o 95°C o 1 min
ollowed by annealing a 37°C o 1 h and allowed o cool
slowly o e nigh o oom empe a u e. All siRNA oligonu-
cleo ides we e syn hesized comme cially (Dha macon,
La aye e, CO) using 2'ACE p o ec ion chemis y.
In i o siRNA in e e ence
Semi-con luen J774A.1 cells we e cul u ed a 1 × 105
cells/ml in an ibio ic ee, 8% ( / ) endo oxin-low e al-
cal se um RPMI (Gibco-In i ogen, Paisley, UK) con ain-
ing L-glu amine (Sigma, Poole, UK) 12–16 h be o e ans-
ec ion. Fo siRNA ans ec ions 3 µl o a 20 µM siRNA
duplex ( a ge o con ol) solu ion was mixed wi h 47 µl
o Op i-mem (Gibco-In i ogen). In a second ube 3 µl o
oligo ec amine (Gibco-In i ogen) was mixed wi h 12 µl
o Op i-mem and incuba ed a oom empe a u e o 15
min. Solu ions we e combined o 40 min and b ough o
a inal olume o 100 µl. The exp ession o IL-12p40
mRNA and IL-12p70 p o ein was induced by he addi ion
o 1 µg/ml E. coli LPS Se o ype 0111:B4 (Sigma) and 10
ng/ml IFN-γ (Pha mingen, San Diego, CA.), o he las
12 h o each cul u e pos siRNA ans ec ion.
RNA isola ion and semi-quan i a i e RT-PCR (sqRT-PCR)
To al cellula RNA was isola ed om J774A.1 cells om in
i o expe imen s wi h TRIZOL Reagen (Gibco-In i o-
gen) ollowing he manu ac u e 's p o ocol and quan i-
ied by spec opho ome y. RNA was e e se ansc ibed,
and 100 ng o he complemen a y DNA p oduc ampli-
ied by PCR as p e iously desc ibed [51] using 60 ng o
gene speci ic ups eam and downs eam p ime s. Mu ine
β-ac in p oduc was used o no malize RNA samples. PCR
condi ions included a p e-incuba ion a 95°C o 5 min
ollowed by 35 ampli ica ion cycles (95°C, 1 min; 1 min
a annealing empe a u e; 2 min a 72°C, and a inal 10
min a 72°C). Ups eam and downs eam p ime s o IL-
12p40 we e speci ically designed o lank he IL-12p40
siRNA a ge egion; sense, 5'-AAACAGTGAACCTCACCT-
GTGACAC-3' ; an isense, 5'-TTCATCAGCAAGTTCTT-
GGGCG-3'. PCR p oduc s we e isualized by UV
illumina ed aga ose gel elec opho esis.
In i o siRNA in e e ence
Con ol mice (BALB/c & IL12p40-/-) ecei ed 200 µl Op i-
mem in a-pe i oneal (i.p.) con aining oligo ec amine
alone. In addi ion LPS posi i e con ol mice ecei ed 1 µg
E. coli LPS. Fo each expe imen al adminis a ion, 10 µl
siRNA duplexes (IL-12p40 o con ols a equimola con-
cen a ion) we e p emixed wi h 40 µl o Op i-mem. Sepa-
a ely, 6 µl o oligo ec amine was mixed wi h 24 µl o
Op i-mem and incuba ed a oom empe a u e o 15
min. These solu ions we e mixed a oom empe a u e o
40 min. Fo co-injec ion expe imen s, hese we e com-
bined wi h LPS (1 µg/mouse) and o mula ed as abo e.
Fo he apeu ic silencing, mice ecei ed 1 µg LPS, in he
absence o siRNA duplexes, 1 h p io o adminis a ion o
siRNA (IL-12p40 o con ols) as abo e. A a ious ime
poin s, blood se um, pe i oneal cells o la age luid we e
sampled o u he analysis.
Pe i oneal La age & Se um p epa a ion
Pe i oneal cells we e ha es ed by washing he pe i oneal
ca i y wi h 1 ml o s e ile PBS. This was cen i uged o 5
min a 400 g, la age supe na an was emo ed o analysis
and cells analysed by low cy ome y. Se um was p epa ed
by ca diac punc u e. Se a and la age supe na an s we e
assayed wi hou delay o s o age.
Flow Cy ome y
Pheno ypic analysis o siRNA- ans ec ed cells was pe -
o med using a FACScalibu ™ wi h associa ed Cellques ™
so wa e (Bec on Dickinson, San Jose, CA). Fo wa d and
side sca e we e measu ed om pe i oneal la age p epa-
a ions a 12, 24 and 48 h in esponse o simul aneous
deli e y o IL-12p40 siRNA and LPS, and a 24 h o hose
mice ecei ing he apeu ic IL-12p40 siRNA pos LPS
adminis a ion. Cell su ace ma ke analysis o CD11b,
CD14, CD40, CD80, CD86, F4/80 and MHC class II by
J774A.1 cells was pe o med as p e iously desc ibed [52],
con ol samples included cells incuba ed wi h iso ype
ma ched, di ec ly conjuga ed, con ol an ibodies as
app op ia e.
Analysis o cy okine p oduc ion
Cy okine p oduc ion om in i o expe imen s was
assayed using comme cially a ailable immunoassays o
mouse IL-12p70, IFN-γ, IFN-β, IL-10, and IL-4 (Pha min-
gen). Mouse IL-12p40 in blood se um and pe i oneal la -
age luid was assayed using mu ine IL-12p40 ELISA (R&D
sys ems, Abingdon, UK) acco ding o he manu ac u e 's
ins uc ions.
S a is ical analysis
One-way ANOVA was used o de e mine signi icance o
cy okine p oduc ion be ween g oups; pos es analyses
we e no pe o med. The s uden -Tes was used o de e -
mine he signi icance o di e en luo escen in ensi ies
ob ained by low cy ome y.
Jou nal o In lamma ion 2004, 1:4 h p://www.jou nal-in lamma ion.com/con en /1/1/4
Page 4 o 12
(page numbe no o ci a ion pu poses)
siRNA in e e ence o IL-12 ansc ip ion and ansla ion in i oFigu e 1
siRNA in e e ence o IL-12 ansc ip ion and ansla ion in i o. J744A.1 cells we e ans ec ed wi h IL-12p40 siRNA o di e -
en pe iods (24–72 h). Fo he las 12 h o cul u e, cells we e s imula ed wi h LPS/IFN-γ o wi h PBS (-LPS, he ea e e med
uns imula ed). Exp ession o IL-12p40 (A) was de e mined by sqRT-PCR. Samples we e no malized o β-ac in exp ession
(lowe panel A). Con ol siRNA ans ec ions included naked siRNA o IL-12p40, mu an siRNA o IL-12p40 and GFP (B). IL-
12p70 p o ein exp ession was de e mined by ELISA (C). Da a a e ep esen a i e o a leas ou independen expe imen s; IL-
12p70 p o ein concen a ion is exp essed as he mean (+/-SEM) om iplica e cul u es (n = 3) on each occasion.
Jou nal o In lamma ion 2004, 1:4 h p://www.jou nal-in lamma ion.com/con en /1/1/4
Page 5 o 12
(page numbe no o ci a ion pu poses)
Resul s
IL-12 p40 siRNA knocks down IL-12 exp ession in i o
To in es iga e silencing o cy okine gene exp ession in
i o, he mu ine mac ophage-like cell line J774A.1 was
ansien ly ans ec ed wi h siRNA a ge ing IL-12p40 o
he ime poin s shown in Fig. 1 (24, 48, 72 h). These cells
we e s imula ed o he inal 12 h o each expe imen ,
wi h LPS and IFN-γ (LPS/IFN-γ), a p o ocol ha induces
IL-12p70 [30]. T ans ec ion wi h IL-12p40 siRNA esul ed
in a signi ican supp ession o p40 mRNA and a conse-
quen loss o de ec able IL-12p70 in cell cul u e supe na-
an (Fig. 1A,1B,1C). A educ ion in IL-12p40 mRNA was
obse ed a 24 h, bu silencing was mo e p onounced a
48 h. T ans ec ion o 72 h wi h IL-12p40 siRNA was in e-
io o ei he 24 o 48 h, as IL-12p40 mRNA exp ession
and IL-12p70 p o ein syn hesis began o eco e by his
ime (Fig. 1A &1C). Thus siRNA silencing was ansien in
his sys em. Con ol siRNA ans ec ions included siRNA
o IL-12p40 wi hou ans ec ion agen (naked siRNA),
siRNA o IL-12p40 whe e he 10 h and 11 h bases we e
e e sed (mu an siRNA), and siRNA a ge ing GFP, a p o-
ein ha does no na u ally occu in J774A.1 cells. These
con ol siRNAs did no induce IL-12p40 mRNA exp es-
sion (Fig. 1B). Ou esul s show sequence-speci ic siRNA
media ed inhibi ion o IL-12p40 mRNA syn hesis in i o
a 48 h pos siRNA incuba ion (Fig. 1A). ELISA con i med
he siRNA media ed silencing o IL-12p70 p o ein exp es-
sion (Fig. 1C), e lec ing he signi ican inhibi ion o IL-
12p40 mRNA syn hesis (p < 0.001, compa ed o LPS/IFN-
γ g oup). Supe na an s om uns imula ed cells, o cells
incuba ed wi h con ol siRNAs, showed no IL-12p70 p o-
ein p oduc ion. Supp ession o IL-12p70 was ansien ,
wi h le els eco e ing a he emaining ime poin s.
mRNA exp ession p o iling o he in lamma o y
cy okines IFN-β, IL-12p35, IL-23p19, IL-6, IL-10 and IFN-
γ in IL-12p40 o con ol silenced cells, showed no non-
speci ic siRNA silencing a he doses employed (Table 1).
Con ol siRNA deli e ed by he same p o ocol did no
induce mRNA o IFN-β, IL-12p35, IL-23p19, IL-6, IL-10
and IFN-γ. Likewise, cells ans ec ed wi h IL-12p40 siRNA
showed no modula ion o he p o ein le els o IL-4, IL-5,
IL-6, IL-10, and TNF-α ( esul s no shown). One cy okine
did no ollow his pa e n. Al hough IL-12p40 siRNA
ans ec ion o s imula ed mac ophages did no esul in a
de ec able educ ion o IFN-γ mRNA (Table 1 and Fig.
2A), a educ ion o de ec able IFN-γ p o ein was obse ed
(Fig. 2B). This disc epancy be ween IFN-γ mRNA and p o-
ein de ec ion may e lec he ole o IL-12p40 in pos -
ansc ip ional egula ion o IFN-γ sec e ion [31] and is
consis en wi h he iming o IFN-γ p o ein syn hesis and
sec e ion p e iously obse ed in LPS challenged IL-12p40-
/- mice in i o [32].
Silencing IL-12p40 educes LPS/IFN-
γ
d i en mac ophage
ac i a ion in i o
To de e mine whe he silencing IL-12p40 had b oade
e ec s on mac ophages, he exp ession o he ac i a ion/co-
s imula o y ma ke s CD40, CD80, CD86, and MHC class II
was examined ollowing simul aneous exposu e o J774
cells o LPS/IFN-γ and ei he con ol o IL-12p40-speci ic
siRNA. Exp ession o CD14, a componen o he LPS ecog-
ni ion machine y was also examined. LPS/IFN-γ s imula-
ion alone (24 h) esul ed in inc eased CD40, CD86 and
MHC class II exp ession (Table 2), bu had no e ec on
CD80 o CD14 as expec ed. IL-12p40-speci ic siRNA did
no ac i a e mac ophages in he absence o LPS/IFN-γ
(Table 2). In he p esence o LPS/IFN-γ, siRNA a ge ing IL-
12p40 p e en ed inc eased exp ession o CD40, and CD86,
sugges ing ha silencing IL-12 in e e ed wi h mac ophage
ac i a ion. The exp ession o CD80, CD14 and MHC class
II we e no a ec ed (Table 2). In con as , Mu .siRNA did
no p e en CD86 up egula ion when cells we e s imula ed
wi h LPS/IFN-γ bu a he esul ed in inc eased exp ession,
sugges ing ha his sequence may con ibu e o mac o-
phage ac i a ion no seen wi h IL-12p40 speci ic siRNA.
The exp ession o he mac ophage pheno ypic ma ke s
CD11b and F4/80 we e unchanged in all expe imen s, no
signi ican di e ence was seen in le els o apop osis
be ween g oups (da a no shown).
Table 1: IL-12p40 siRNA speci ically silences mRNA o IL-12p40
and no o he cy okines.
Ta ge Silencing by ea men a
LPS/IFN-γ:- + +
SiRNA: IL-12p40 Mu .siRNA IL-12p40
β-Ac in - - -
IL-12p40 - - +
IL-12p35 - - -
IL-23p19 - - -
IFN-γ---
IFN-β---
TNF-α---
IL-4 - - -
IL-5 - - -
IL-6 - - -
IL-10 - - -
aJ774 cells we e incuba ed wi h o wi hou LPS/IFN-γ and speci ic o
con ol siRNA as desc ibed in he ma e ials and me hods sec ion.
mRNA o di e en a ge s we e de ec ed by sqRT-PCR. In his able
silencing (+) is de ined as he loss o a isible band om s imula ed
cul u es; he - symbol indica es ei he no loss o a isible band om
s imula ed (siRNA + LPS/IFN-γ) cul u es, o no isible al e a ion
(induc ion o loss) in uns imula ed (siRNA – LPS/IFN-γ) cul u es. All
esul s ep esen a leas wo expe imen s pe o med in iplica e.

Jou nal o In lamma ion 2004, 1:4 h p://www.jou nal-in lamma ion.com/con en /1/1/4
Page 6 o 12
(page numbe no o ci a ion pu poses)
Silencing IL-12p40 in luences IFN-γ p o ein exp ession.Figu e 2
Silencing IL-12p40 in luences IFN-γ p o ein exp ession. The in luence o silencing IL-12p40 on he exp ession o IFN-γ was
de e mined using he condi ions desc ibed in Fig. 1, by sqRT-PCR o IFN-γ mRNA (A) o by ELISA o IFN-γ p o ein p esen
in cul u e supe na an (B). Da a a e ep esen a i e o a leas ou independen expe imen s; IFN-γ p o ein concen a ion is
exp essed as he mean (+/-SEM) om iplica e cul u es (n = 3) on each occasion. Le els o IFN-γ a e signi ican ly educed in
he p esence o IL-12p40 siRNA o 24, 48, and 72 h (p < 0.0001) when compa ed o s imula ed non-silenced cul u es.
Table 2: LPS/IFN-γ d i en mac ophage exp ession o CD40 and CD86 is modula ed by IL-12p40 siRNA.
T ea men Mean Fluo escen In ensi y (+/-SEM)
LPS/IFN-γsiRNA CD40 CD86 CD80 CD14 MHCII
- - 22 (5) 9 (4) 34 (8) 44 (11) 19 (8)
- IL-12p40 16 (9) 14 (1) 29 (2) 49 (4) 18 (8)
+ - 290 (27) 41(5) 102 (21) 86 (11) 46 (5)
+ IL-12p40 94 (17)* 7 (1)* 66 (13) 47 (9) 46 (5)
+ Mu .siRNA 241 (18) 72 (6) 102 (4) 86 (16) 43 (5)
Da a a e he mean ± SEM o nea es whole numbe o MFI o 3 independen expe imen s, each pe o med in iplica e (n = 3), * s a is ical
signi icance (α = 0.05) compa ed o cells s imula ed wi h LPS/IFN-γ in he absence o IL-12p40 siRNA.
Jou nal o In lamma ion 2004, 1:4 h p://www.jou nal-in lamma ion.com/con en /1/1/4
Page 7 o 12
(page numbe no o ci a ion pu poses)
siRNA a ge ing IL-12p40 speci ically educes LPS d i en
in lamma ion in i o
We in es iga ed he possibili y o silencing IL-12 by RNA
in e e ence in i o, using a well-es ablished mu ine
model o LPS d i en pe i oneal in lamma ion [33,34].
The deli e y o LPS i.p. esul ed in inc eased ac i a ed
phagocy ic cells de ec able a 12, 24 and 48 h by la age,
compa ed o con ols (Fig. 3A g oups I & II). This e ec
was g ea ly educed in IL-12p40-/- mice. Simul aneous
deli e y o a con ol i ele an siRNA (GFPsiRNA) o a
mu an IL-12p40 siRNA (Mu .siRNA) duplex con aining
wo misma ches o he IL-12p40 speci ic sequence had no
in luence on LPS d i en in lamma ion. Likewise, a con ol
siRNA ha was he an isense o he unc ional duplex
(As.siRNA) did no esul in a signi ican educ ion in he
le el o ac i a ed phagocy ic cells. Howe e , deli e y o IL-
12p40 siRNA d ama ically educed he le els o in lam-
ma ion (Fig. 3A) a 12, 24 and 48 h. Deli e y o encapsu-
la ed siRNA did no esul in inc eased in cell dea h o
pe i oneal cells (apop osis o nec osis) compa ed o con-
ols a he ime poin s selec ed (da a no shown).
Con ol wild ype and IL-12p40-/- mice showed no in lam-
ma o y esponse o siRNA ans ec ion eagen s alone (Fig.
3). LPS challenged wild ype mice, and mice co-challenged
wi h con ol siRNAs displayed a ypical in lamma o y cell
esponse in he pe i oneal ca i y wi h inc eased numbe s o
ac i a ed phagocy ic cells, a 24 h (19.8%, 16.8 %, 22.01%)
and 48 h (22.53%, 17.95% 16.64%) compa ed o con ol
unchallenged mice (2.17% and 3.46%). Simila esul s
we e obse ed in mice co-challenged wi h LPS and
As.siRNA a 24 and 48 h (18.9% and 23.64% espec i ely).
Howe e , mice co-adminis e ed LPS and speci ic IL-12p40
siRNA displayed educed numbe s o ac i a ed cells
(6.3%), mi o ing he educed in lamma o y esponse seen
in LPS challenged IL-12p40-/- mice (7.3%) a 24 h. How-
e e , modula ion o he in lamma o y esponse in he LPS-
IL-12p40 siRNA challenged mice was no pe manen . An
inc ease in ac i a ed phagocy ic cells (11.10%) was seen a
48 h, al hough le els we e s ill lowe han he LPS chal-
lenged BALB/c mice (22.53%), (Fig. 3A &3C). Thus, siRNA-
media ed silencing o IL-12p40 mRNA in his model has a
signi ican bu non-pe manen e ec on he abili y o medi-
a e a esponse o LPS challenge in i o.
siRNA a ge ing o he p oin lamma o y cy okine IL-12p40
can be used as a he apeu ic in e en ion agains
in lamma ion d i en by mic obial p oduc s
In o de o explo e he po en ial use o siRNA in a mo e
he apeu ic con ex and based on he indings abo e, we
deli e ed IL-12p40 siRNA by di ec injec ion in o he
pe i oneal ca i y, 1 h pos LPS challenge. Adminis a ion
o IL-12p40 siRNA pos LPS challenge (Fig. 3B I-VI)
esul ed in a dec ease in he numbe o ac i a ed phago-
cy ic cells, (4.22%) a 24 h, when compa ed o mice
ecei ing LPS only (16.64%), con ol siRNAs (Mu .siRNA
and GFPsiRNA) o As.siRNA, (25.03%, 17.07% and
12.63% espec i ely). These da a demons a e ha IL-
12p40 siRNA can be used he apeu ically o speci ically
silence a cy okine-d i en in lamma o y esponse in i o, i
deli e ed a a sui able momen .
In pa allel expe imen s, he local and sys emic e ec s o
siRNA media ed silencing we e assessed. IL-12p40 siRNA
co-deli e ed wi h LPS o adminis e ed pos LPS insul , had
bo h local and sys emic an i-in lamma o y e ec s (Fig. 4).
Con ol BALB/c mice gi en siRNA ans ec ion eagen s
alone, showed low le els o IL-12p40 p o ein exp ession in
blood se um and pe i oneal la age samples (103 pg/ml
and 75 pg/ml espec i ely). Howe e , mice challenged wi h
LPS, o co-challenged wi h LPS and con ol siRNAs (GFP-
siRNA, Mu .siRNA)(Fig. 4) showed signi ican inc eases in
IL-12p40 p o ein de ec ed in bo h se um and la age com-
pa ed o con ol (p < 0.05). Deli e y o As.siRNA did esul
in educed se um IL-12p40 p o ein bu only when admin-
is e ed he apeu ically (Fig. 4B). S ikingly, deli e y o IL-
12p40 siRNA deli e ed simul aneous o, o 1 h pos LPS
adminis a ion, esul ed in a signi ican educ ion in he
le els o IL-12p40 p o ein de ec ed in all se um and pe i o-
neal la age samples compa ed o LPS alone (p < 0.05, in
each case) (Fig. 4). Deli e y o nega i e con ol siRNAs
showed no such educ ion. Ou indings demons a e ha
well designed sequence speci ic siRNA can p o ide a signi -
ican he apeu ic e ec and elici local and sys emic p o ec-
ion agains in lamma ion.
Discussion
The abili y o e icien ly deli e small in e e ing RNA o
modula e gene exp ession in i o may p o ide new
he apeu ic app oaches o cu en ly in ac able diseases.
We ini ially demons a e ha in i o IL-12p40 siRNA spe-
ci ically silenced i s mRNA homologue leading o an-
sien silencing o IL-12p40 p o ein and consequen
knockdown o IL-12p70 exp ession. This app oach did
no a ge o he p oin lamma o y cy okines (IL-6, IL-23,
IL-10, TNF-α), o RNA-induced gene silencing, no did
con ol siRNA induce hese cy okines o ype I in e e on
a he concen a ions employed. Fu he mo e, we demon-
s a e ha his app oach can be ex ended in i o by show-
ing ha silencing o IL-12p40 esul s in he non-
pe manen supp ession o IL-12 in a mu ine model o
pe i oneal in lamma ion. Such silencing is e iden in he
educed le els o IL-12 de ec able locally in pe i oneal la -
age and sys emically in blood se um. Finally, we show
ha siRNA can be used he apeu ically a e he ini ia ion
o an in lamma o y esponse o knockdown IL-12 exp es-
sion and o educe he obse ed in lamma o y in il a e
seen in his model.
Jou nal o In lamma ion 2004, 1:4 h p://www.jou nal-in lamma ion.com/con en /1/1/4
Page 8 o 12
(page numbe no o ci a ion pu poses)
Silencing o IL-12 by siRNA in e e es wi h he in lamma o y esponse in i oFigu e 3
Silencing o IL-12 by siRNA in e e es wi h he in lamma o y esponse in i o. siRNA was deli e ed wi h LPS (A) o he apeu i-
cally 1 h pos LPS s imula ion (B). Mice ecei ed ans ec ion eagen s only (no siRNA) (g oup I), LPS alone (g oup II) o we e
co-injec ed wi h LPS and con ol siRNAs (g oup III-V, As.siRNA, GFPsiRNA, and Mu .siRNA espec i ely) o LPS and IL-12p40
speci ic siRNA (g oup VI). In lamma ion was cha ac e ized by low cy ome y o pe i oneal la age a 12, 24 and 48 h. The ypi-
cal in lamma o y cell esponse in he pe i oneal ca i y is shown in he enclosed egion. Con ol IL-12p40-/-mice showed he
cha ac e is ic ge m-line knockou esponse o LPS h oughou he expe imen (g oup VII). IL-12p40 siRNA was also deli e ed
he apeu ically (B) 1 h pos LPS challenge, and in lamma ion measu ed a 24 h. Mice ecei ing con ol siRNAs (g oups III-V) dis-
played a simila in lamma o y esponse o mice ecei ing LPS insul alone (g oup II). Mice ecei ing IL-12p40 siRNA (g oup VI)
displayed a educed numbe o ac i a ed phagocy ic cells a he same ime poin (enclosed egion). Da a a e ep esen a i e o
a leas h ee independen expe imen s (G oups I-VI) o wo expe imen s (G oup VII). In each expe imen , n = a leas 4 mice
on each occasion. The absolu e numbe s o cells p esen in la age luid, ep esen ed by he enclosed egion in A, a e illus a ed
(C). Da a in ba cha s ep esen he mean numbe o cells (+/-SEM)/ml la age luid om ou mice a he ime poin s indica ed.
Jou nal o In lamma ion 2004, 1:4 h p://www.jou nal-in lamma ion.com/con en /1/1/4
Page 9 o 12
(page numbe no o ci a ion pu poses)
siRNA silencing IL-12p40 educes local and sys emic le els o IL-12p40 p o einFigu e 4
siRNA silencing IL-12p40 educes local and sys emic le els o IL-12p40 p o ein. LPS deli e y o he pe i oneal ca i y wi h simul-
aneous (whi e ba s), o he apeu ic adminis a ion (black ba s) o IL-12p40 speci ic siRNA educed he appea ance o IL-
12p40 p o ein in se um (A) and pe i oneal la age (B) as measu ed by IL-12p40 speci ic ELISA. Se um and la age we e sampled
a 6 h pos LPS challenge. IL-12p40 obse ed in se um o la age om LPS challenged mice o mice co-challenged wi h LPS and
ei he GFPsiRNA o Mu .siRNA was signi ican ly g ea e han con ol (p < 0.05, in bo h cases). IL-12p40 siRNA when deli -
e ed simul aneously o he apeu ically signi ican ly educed IL-12p40 p o ein p oduc ion compa ed o LPS challenge alone (p <
0.05, in each case). Da a a e ep esen a i e o h ee independen expe imen s whe e n = 4 on each occasion; IL-12p40 p o ein
concen a ion is exp essed as he mean (+/-SEM) om iplica e samples.